KYOWA KIRIN CO. LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,694 JPY | +0.13% |
|
-1.97% | +13.65% |
| 06-05 | Kyowa Kirin Repurchases 3.3 Million Shares in May | MT |
| 05-07 | Kyowa Kirin's Profit Up 15% in Q1 | MT |
| Sales 2024 * | 473B 2.96B 234B | Sales 2025 * | 485B 3.03B 240B | Capitalization | 1,426B 8.92B 706B |
|---|---|---|---|---|---|
| Net income 2024 * | 66.65B 417M 32.98B | Net income 2025 * | 72.49B 453M 35.87B | EV / Sales 2024 * | 2.32 x |
| Net cash position 2024 * | 328B 2.05B 162B | Net cash position 2025 * | 360B 2.25B 178B | EV / Sales 2025 * | 2.2 x |
| P/E ratio 2024 * |
21.4
x | P/E ratio 2025 * |
19.7
x | Employees | 5,974 |
| Yield 2024 * |
2.18% | Yield 2025 * |
2.28% | Free-Float | 45.41% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | +0.13% | ||
| 1 week | -1.97% | ||
| Current month | +1.43% | ||
| 1 month | +3.96% | ||
| 3 months | -5.33% | ||
| 6 months | +16.05% | ||
| Current year | +13.65% |
1 week
2 629.50
2 769.00
1 month
2 536.002 769.00
Current year
2 266.503 009.00
1 year
2 266.503 009.00
3 years
2 266.504 240.00
5 years
1 674.004 240.00
10 years
1 094.004 240.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 31/03/86 | |
Masashi Miyamoto
PSD | President | 64 | 31/03/85 |
| Chief Tech/Sci/R&D Officer | 62 | 31/03/10 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Takashi Oyamada
BRD | Director/Board Member | 68 | 28/02/21 |
Yoshihisa Suzuki
BRD | Director/Board Member | 69 | 28/02/22 |
| Director/Board Member | 66 | 30/09/08 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.22% | 14 M€ | +9.47% | ||
| 0.44% | 10 M€ | +15.19% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/06/24 | 2,694 | +0.13% | 1,153,400 |
| 20/06/24 | 2,690 | +0.39% | 731,100 |
| 19/06/24 | 2,680 | +1.11% | 1,431,500 |
| 18/06/24 | 2,650 | -2.48% | 1,424,700 |
| 17/06/24 | 2,718 | -1.09% | 1,072,700 |
Delayed Quote Japan Exchange, June 21, 2024 at 07:00 am
More quotes
Kyowa Kirin Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows:
- sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment;
- sales of licenses (7.4%).
At the end of 2021, the group had 3 production sites located in Japan (2) and China.
Net sales break down geographically as follows: Japan (60.9%), Asia (9%), Americas (16.3%) and Europe (13.8%).
Sector
Pharmaceuticals
Calendar
26/06/2024
- Détachement de for dividende intermédiaire
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
2,694
JPY
Average target price
3,054
JPY
Spread / Average Target
+13.39%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +13.65% | 8.94B | |
| +15.72% | 77.46B | |
| -24.30% | 4.28B | |
| +12.79% | 4.18B | |
| +31.45% | 4.11B | |
| +10.97% | 2.23B | |
| -30.57% | 2.06B | |
| +8.99% | 1.97B | |
| -45.76% | 1.69B | |
| -0.50% | 1.64B |
- Stock Market
- Equities
- 4151 Stock
